[Federal Register Volume 85, Number 208 (Tuesday, October 27, 2020)]
[Notices]
[Pages 68089-68090]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-23696]


=======================================================================
-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[Investigation Nos. 731-TA-1229-1230 (Review)]


Monosodium Glutamate From China and Indonesia

Determination

    On the basis of the record \1\ developed in the subject five-year 
reviews, the United States International Trade Commission 
(``Commission'') determines, pursuant to the Tariff Act of 1930 (``the 
Act''), that revocation of the antidumping duty orders on monosodium 
glutamate (``MSG'') from China and Indonesia would be likely to lead to 
continuation or recurrence of material injury to an industry in the 
United States within a reasonably foreseeable time.
---------------------------------------------------------------------------

    \1\ The record is defined in Sec.  207.2(f) of the Commission's 
Rules of Practice and Procedure (19 CFR 207.2(f)).
---------------------------------------------------------------------------

Background

    The Commission instituted these reviews on October 1, 2019 (84 FR 
52129) and determined on January 6, 2020 that it would conduct full 
reviews (85 FR 3421, January 21, 2020). Notice of the scheduling of the 
Commission's reviews and of a public hearing to be held in connection 
therewith was given by posting copies of the notice in the Office of 
the Secretary, U.S. International Trade Commission, Washington, DC, and 
by publishing the

[[Page 68090]]

notice in the Federal Register on May 13, 2020 (85 FR 28663). In light 
of the restrictions on access to the Commission building due to the 
COVID-19 pandemic, the Commission conducted its hearing through written 
testimony and video conference on August 25, 2020. All persons who 
requested the opportunity were permitted to participate.
    The Commission made these determinations pursuant to section 751(c) 
of the Act (19 U.S.C. 1675(c)). The Commission determined that these 
reviews were extraordinarily complicated and extended the review period 
by up to 90 days. It completed and filed its determinations in these 
reviews on October 21, 2020. The views of the Commission are contained 
in USITC Publication 5127 (October 2020), entitled Monosodium Glutamate 
from China and Indonesia: Investigation Nos. 731-TA-1229-1230 (Review).

    By order of the Commission.

    Issued: October 21, 2020.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2020-23696 Filed 10-26-20; 8:45 am]
BILLING CODE 7020-02-P